Synbiotic Health develops new probiotic strains for humans and companion animals, discovered through the use of their proprietary IVS and IVE platforms, allowing for the isolation of new microbes based on selective and competitive conditions.
Studies
Two-week supplementation of Bifidobacterium adolescentis iVS-1 reduces symptoms associated with lactose intolerance in lactose maldigesters.
Ramakrishnan et al. (2025), Gut Microbes Reports, 2(1).
Complete genome sequence of the probiotic Bifidobacterium adolescentis strain iVS-1.
Chacón-Vargas et al. (2023), Microbiology Resource Announcements, Vol. 12(12).
A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults.
Davis et al, 2010
Barcoded Pyrosequencing Reveals That Consumption of Galactooligosaccharides Results in a Highly Specific Bifidogenic Response in Humans.
Davis et al, 2011
White Papers
Lactose Intolerance
Folate
Canine
B. adolescentis
Healthy Aging